Global Cervical Cancer Market 2015-2019 is the latest addition to Sandlerresearch.org industry research reports collection. The analysts forecast global cervical cancer market to grow at a CAGR of 4.87% over the period 2014-2019. Read this 70 Pages report on Global Cervical Cancer Market 2015-2019; the report provides 34 Exhibits. Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world’s fourth most common cause of death in women. The disease can be classified as squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma originates in the lining of the cervix, while adenocarcinoma arises in cervical cells. Cervical cancer is caused due to the infection of HPV. There are no signs and symptoms to identify the early stages of cervical cancer, but it can be identified through regular check-ups. Vaginal bleeding and pelvic pain are usually observed as signs and symptoms of cervical cancer. Before cancer detected in the cervix, cervix cells go through changes, called as dysplasia, in which abnormal cells start to expose in the cervical tissue. Over a period, the abnormal cells may developed into cancer cells and begin to grow and spread more deeply into the cervix and surrounding areas. Covered in this Report The report covers current scenario and the growth prospects of the global cervical cancer market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various drugs used in the treatment and prevention of cervical cancer. The report, Global Cervical Cancer Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global cervical cancer market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Purchase a Report Copy at http://www.sandlerresearch.org/purchase?rname=43500 . Alternatively get Discount on the Report at http://www.sandlerresearch.org/discount?rname=43500 . Single User License: US $2500 Special Offer on Technavio/Infiniti Reports Buy 3 reports at the Cost of 2 (Lowest Priced Report will be free)/ Buy 3 Reports of the Same Price for the Cost of 2. Buy 4 or more Reports and get 50% flat discount on the total price. [IMP Note: This Offer Only Valid Via Email To sales@sandlerresearch.org OR Call +1-888-391-5441] Key regions
Americas APAC EMEA
Key vendors
F. Hoffmann-La Roche GlaxoSmithKline Merck
Other prominent vendors
Advaxis Immunotherapies Bionor Pharma Dendreon Corporation Inovio Pharmaceuticals ISA Pharmaceuticals Otsuka Pharmaceuticals Profectus Biosciences Virometix Zeria Pharmaceuticals Inquire before Buying at http://www.sandlerresearch.org/inquire-before-buying?rname=43500 . Key market driver
Increase in incidence rate
Key market challenge
Adverse effects of drugs and vaccines
Key market trend
Patient assistance programs
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
List of Exhibits: Exhibit 01: Risk factors for cervical cancer Exhibit 02: Screening tests for cervical cancer Exhibit 03: Diagnostic tests for cervical cancer Exhibit 04: FIGO staging for cervical cancer
Exhibit 05: Management of cervical cancer Exhibit 06: Chemotherapy for treatment of cervical cancer Exhibit 07: Cervical cancer treatment algorithm Exhibit 08: Countries with highest cervical cancer rates Exhibit 09: Cervical cancer deaths by age group in the US 2008-2012 Exhibit 10: Age-specific incidence rates of cervical cancer in the US by race 2008-2012 Exhibit 11: Age-specific mortality rates of cervical cancer of women in the US by race 2008-2012 Exhibit 12: Mortality rates of cervical cancer of women in the US by race 2008-2012 Exhibit 13: Average number of cervical cancer deaths in EU 2010-2012 Exhibit 14: Cervical cancer incidence and mortality rates in EU 2007-2011 Exhibit 15: Global cervical cancer therapeutics market 2014-2019 ($ billions) Exhibit 16: Global cervical cancer therapeutics market segmentation by application Exhibit 17: Global prophylactic vaccines market 2014-2019 ($ millions) Exhibit 18: Global therapeutic drugs market 2014-2019 ($ millions) Exhibit 19: Segmentation of global cervical cancer therapeutics market 2014 Exhibit 20: Global cervical cancer therapeutics market by type of therapy Exhibit 21: Segmentation of global cervical cancer therapeutics market by region 2014 Exhibit 22: Global cervical cancer vaccines market: Comparison of major brands Exhibit 23: Gardasil, Gardasil 9, and Cervarix: A comparative study Exhibit 24: Key late-stage HPV vaccines for cervical cancer Exhibit 25: Drivers of global cervical cancer therapeutics market Exhibit 26: Impact of drivers Exhibit 27: Challenges of global cervical cancer therapeutics market Exhibit 28: Impact of drivers and challenges
Exhibit 29: Trends of global cervical cancer therapeutics market Exhibit 30: Gardasil: Global revenue and growth rate 2011-2014 Exhibit 31: Merck: Key takeaways Exhibit 32: Cervarix: Global revenue and growth rate 2012-2014 Exhibit 33: GSK: Key takeaways Exhibit 34: F. Hoffman-La Roche: Key takeaways Browse Other Reports on Pharmaceutical . Contact sales@sandlerresearch.org / Call +1 888 391 5441 for further information on “Global Cervical Cancer Market 2015-2019� report OR for any other market research and intelligence needs you may have for your business. About Us: Sandlerresearch.org is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business. NOTE: This Report Is NOT Free Of Charge.